These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 31156618)

  • 21. Complement cascade inhibition in geographic atrophy: a review.
    Desai D; Dugel PU
    Eye (Lond); 2022 Feb; 36(2):294-302. PubMed ID: 34999723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zinc supplementation inhibits complement activation in age-related macular degeneration.
    Smailhodzic D; van Asten F; Blom AM; Mohlin FC; den Hollander AI; van de Ven JP; van Huet RA; Groenewoud JM; Tian Y; Berendschot TT; Lechanteur YT; Fauser S; de Bruijn C; Daha MR; van der Wilt GJ; Hoyng CB; Klevering BJ
    PLoS One; 2014; 9(11):e112682. PubMed ID: 25393287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimentally-induced anti-myeloperoxidase vasculitis does not require properdin, MASP-2 or bone marrow-derived C5.
    Freeley SJ; Popat RJ; Parmar K; Kolev M; Hunt BJ; Stover CM; Schwaeble W; Kemper C; Robson MG
    J Pathol; 2016 Sep; 240(1):61-71. PubMed ID: 27235854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement alternative pathway activation in human nonalcoholic steatohepatitis.
    Segers FM; Verdam FJ; de Jonge C; Boonen B; Driessen A; Shiri-Sverdlov R; Bouvy ND; Greve JW; Buurman WA; Rensen SS
    PLoS One; 2014; 9(10):e110053. PubMed ID: 25299043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of Checkpoint Ligand Programmed Death-Ligand 1 in Patients with Paroxysmal Nocturnal Hemoglobinuria Explained by Proximal Complement Activation.
    Anliker M; Drees D; Loacker L; Hafner S; Griesmacher A; Hoermann G; Fux V; Schennach H; Hörtnagl P; Dopler A; Schmidt S; Bellmann-Weiler R; Weiss G; Marx-Hofmann A; Körper S; Höchsmann B; Schrezenmeier H; Schmidt CQ
    J Immunol; 2022 Mar; 208(5):1248-1258. PubMed ID: 35173033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
    Medicus RG; Götze O; Müller-Eberhard HJ
    J Exp Med; 1976 Oct; 144(4):1076-93. PubMed ID: 978134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation.
    Paixão-Cavalcante D; López-Trascasa M; Skattum L; Giclas PC; Goodship TH; de Córdoba SR; Truedsson L; Morgan BP; Harris CL
    Kidney Int; 2012 Nov; 82(10):1084-92. PubMed ID: 22854646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monomeric C-reactive protein inhibits renal cell-directed complement activation mediated by properdin.
    O'Flynn J; van der Pol P; Dixon KO; Prohászka Z; Daha MR; van Kooten C
    Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1308-16. PubMed ID: 26984957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Properdin Is a Key Player in Lysis of Red Blood Cells and Complement Activation on Endothelial Cells in Hemolytic Anemias Caused by Complement Dysregulation.
    Chen JY; Galwankar NS; Emch HN; Menon SS; Cortes C; Thurman JM; Merrill SA; Brodsky RA; Ferreira VP
    Front Immunol; 2020; 11():1460. PubMed ID: 32793201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The significance of the complement system for the pathogenesis of age-related macular degeneration - current evidence and translation into clinical application.
    Charbel Issa P; Chong NV; Scholl HP
    Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):163-74. PubMed ID: 21127893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The activation mechanism of human complement system by immune precipitate formed with rabbit IgG antibody.
    Fujita T
    Microbiol Immunol; 1979; 23(10):1023-31. PubMed ID: 514094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anaphylatoxin Signaling in Retinal Pigment and Choroidal Endothelial Cells: Characteristics and Relevance to Age-Related Macular Degeneration.
    Rohrer B
    Adv Exp Med Biol; 2018; 1074():45-51. PubMed ID: 29721926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration.
    Richards A; Kavanagh D; Atkinson JP
    Adv Immunol; 2007; 96():141-77. PubMed ID: 17981206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in Extracellular Matrix/Bruch's Membrane Can Cause the Activation of the Alternative Complement Pathway via Tick-Over.
    Fernandez-Godino R
    Adv Exp Med Biol; 2018; 1074():29-35. PubMed ID: 29721924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of aberrant complement activation by a dimer of acetylsalicylic acid.
    Lee M; Wathier M; Love JA; McGeer E; McGeer PL
    Neurobiol Aging; 2015 Oct; 36(10):2748-56. PubMed ID: 26248865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel antibody against human properdin inhibits the alternative complement system and specifically detects properdin from blood samples.
    Pauly D; Nagel BM; Reinders J; Killian T; Wulf M; Ackermann S; Ehrenstein B; Zipfel PF; Skerka C; Weber BH
    PLoS One; 2014; 9(5):e96371. PubMed ID: 24797388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited.
    Anderson DH; Radeke MJ; Gallo NB; Chapin EA; Johnson PT; Curletti CR; Hancox LS; Hu J; Ebright JN; Malek G; Hauser MA; Rickman CB; Bok D; Hageman GS; Johnson LV
    Prog Retin Eye Res; 2010 Mar; 29(2):95-112. PubMed ID: 19961953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement system and age-related macular degeneration: drugs and challenges.
    Wu J; Sun X
    Drug Des Devel Ther; 2019; 13():2413-2425. PubMed ID: 31409975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the complement system for the management of retinal inflammatory and degenerative diseases.
    Xu H; Chen M
    Eur J Pharmacol; 2016 Sep; 787():94-104. PubMed ID: 26948311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement therapeutics in inflammatory diseases: promising drug candidates for C3-targeted intervention.
    Mastellos DC; Ricklin D; Hajishengallis E; Hajishengallis G; Lambris JD
    Mol Oral Microbiol; 2016 Feb; 31(1):3-17. PubMed ID: 26332138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.